The Patient and HCP Education & Awareness Working Group was created in 2020 as part of the From Testing to Targeted Treatment (FT3) program, and specifically, it is organized around the following the high-level strategic goals:
- to empower patients and HCPs with resources that are accessible, adaptable, and targeted in order to make informed decisions;
- to build awareness of existing evidence and new value cases to articulate and disseminate the value of precision medicine.
The objectives and operational work-plan were co-created with the support of the contributors (belonging to different stakeholder groups, incl. Patients, POs, Industry, Academia) and approved by the Board members.
Begoña Nafría Escalera
Patient Expert Reviewer en Research Involvement and Engagement Journal
Esplugues de Llobregat, Spain
Chief Executive Officer, Genome Creative
Garland, United States
PEOF 2020 slides - From diagnosis to treatment and beyond: personalized medicine – what’s in it for patients and understanding patient needs to make it a reality?
29 Sep 2020 Other